Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Collins

Showing results (41-50 of 267) with videos related to

Pageof 27
Sort By:
European Heart Journal|October 12, 2017
Differential effects of PCSK9 variants on risk of coronary disease and ischaemic strokeJemma C Hopewell, Rainer Malik, Elsa Valdés-Márquez, et al.
International Journal of Epidemiology|April 12, 2003
Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studiesSarah Clark, Linda D Youngman, Alison Palmer, et al.
Heart Asia|June 22, 2016
Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 studyYiping Chen, Lixin Jiang, Margaret Smith, et al.
Journal of the American College of Cardiology|July 2, 2021
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8Rishi Caleyachetty, Thomas Littlejohns, Ben Lacey, et al.
BMJ (Clinical Research Ed.)|May 25, 2005
Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trialJeremy Fairbank, Helen Frost, James Wilson-MacDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2022
New Horizons: the value of UK Biobank to research on endocrine and metabolic disordersJelena Bešević, Ben Lacey, Megan Conroy, et al.
Lancet (London, England)|February 1, 2011
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study, Jonathan Emberson, Derrick Bennett, et al.
The New England Journal of Medicine|September 4, 2008
Analyses of cancer data from three ezetimibe trialsRichard Peto, Jonathan Emberson, Martin Landray, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
International Journal of Epidemiology|December 14, 2011
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-upZhengming Chen, Junshi Chen, Rory Collins, et al.
Pageof 27

Showing results (41-50 of 267) with videos related to

Sort By:
Pageof 27
European Heart Journal|October 12, 2017
Differential effects of PCSK9 variants on risk of coronary disease and ischaemic strokeJemma C Hopewell, Rainer Malik, Elsa Valdés-Márquez, et al.
International Journal of Epidemiology|April 12, 2003
Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studiesSarah Clark, Linda D Youngman, Alison Palmer, et al.
Heart Asia|June 22, 2016
Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 studyYiping Chen, Lixin Jiang, Margaret Smith, et al.
Journal of the American College of Cardiology|July 2, 2021
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8Rishi Caleyachetty, Thomas Littlejohns, Ben Lacey, et al.
BMJ (Clinical Research Ed.)|May 25, 2005
Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trialJeremy Fairbank, Helen Frost, James Wilson-MacDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2022
New Horizons: the value of UK Biobank to research on endocrine and metabolic disordersJelena Bešević, Ben Lacey, Megan Conroy, et al.
Lancet (London, England)|February 1, 2011
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study, Jonathan Emberson, Derrick Bennett, et al.
The New England Journal of Medicine|September 4, 2008
Analyses of cancer data from three ezetimibe trialsRichard Peto, Jonathan Emberson, Martin Landray, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
International Journal of Epidemiology|December 14, 2011
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-upZhengming Chen, Junshi Chen, Rory Collins, et al.
Pageof 27